|
Role of Ataxin-1 in BACE1 Expression and Alzheimers Disease |
5R01AG056775-03 |
SUH, JAEHONG |
NIA |
2020 |
|
ApoE Genotype-Directed Drug Repositioning and Combination Therapy for Alzheimers Disease |
5R01AG057683-04 |
HUANG, YADONG |
NIA |
2020 |
|
Regulation of Neuronal Clearance Pathways via Nuclear Calcium Signaling in Alzheimers Disease |
5R01AG062475-02 |
DOBROWOLSKI, RADOSLAW |
NIA |
2020 |
|
Pyroglutamate-modified Amyloid-B protein as a marker for future cognitive decline in preclinical Alzheimers disease |
5R03AG063235-02 |
AYYAPPAN PILLAI, JAGAN |
NIA |
2020 |
|
HDAC9, Aging and Alzheimers Disease |
5R56AG064895-02 |
LU, XIN-YUN |
NIA |
2020 |
|
Tissue Engineered Total Disc Replacement in a Large Animal Model |
RX-002274-01-A1 |
SMITH, HARVEY |
VA |
2020 |